Resource
Methodology & Validation
Analytical principles supporting a structured, repeatable AI capital authorization determination framework.
Section 1
Analytical Methodology
The Stratify™ AI Capital Risk Instrument evaluates structural exposure associated with AI capital deployment.
Key principles include:
- Deterministic evaluation framework
- Rule-based posture determination
- Structural exposure analysis
- Capital authorization focus rather than model evaluation
The instrument evaluates conditions that influence whether AI investments can successfully scale within an organization.
Section 2
Structural Exposure Framework
The instrument evaluates exposure across five structural vectors:
- Regulatory & Compliance Exposure
- Governance & Oversight
- Data & Infrastructure Fragility
- Organizational Execution Risk
- Capital Allocation Discipline
Each vector captures organizational conditions that influence the success or failure of AI capital deployment.
Section 3
Deterministic Determination Model
Capital authorization posture is derived from rule-based evaluation thresholds rather than subjective advisory scoring.
Key characteristics include:
- repeatable evaluation logic
- transparent posture thresholds
- gating conditions that independently constrain authorization
- consistent determination outcomes
This ensures that organizations receive a structured capital authorization determination rather than an advisory opinion.
Section 4
Capital Authorization Postures
The instrument produces one of three authorization outcomes:
- Pause
- Controlled Investment
- Authorize Deployment
These outcomes represent structured capital authorization postures used by boards and investment committees.
Section 5
Scope of Evaluation
The instrument evaluates organizational exposure associated with AI capital deployment, including:
- governance readiness
- regulatory exposure
- operational execution capability
- capital allocation discipline
The instrument does not evaluate model performance or vendor tools.
Section 6
Regulatory Exposure Overlay
The instrument incorporates exposure mapping aligned with evolving regulatory frameworks such as the EU AI Act.
This overlay helps organizations evaluate potential regulatory classification exposure before deployment.
Section 7
Intended Use
The Stratify™ AI Capital Risk Instrument is designed for organizations evaluating material AI capital deployment decisions.
Typical users include:
- boards of directors
- executive leadership teams
- investment committees
- private equity firms
The instrument informs whether AI capital deployment should proceed under current organizational conditions.